Brain health is an urgent global priority, as neurological disorders and mental illnesses afflict vast populations worldwide. The World Health Organization reports staggering statistics: over one in three individuals experience neurological disorders such as stroke, epilepsy, or Parkinson’s disease, while more than half will endure mental health challenges, including depression, anxiety, or schizophrenia, at some stage in their lives. These figures are projected to escalate significantly with increasing global longevity. Traditional clinical approaches, reliant on episodic testing and self-reporting, often miss subtle, early changes in cognitive and emotional functioning — changes that, if detected sooner, could inform timely interventions and mitigate disease progression.

Responding to this challenge, the UNIGE team embarked on an ambitious longitudinal study aimed at discovering if ubiquitous connected devices could continuously and objectively assess brain health markers over extended periods in real-world settings. The study enlisted 88 volunteers aged 45 to 77, a demographic representative of middle-aged to older adults, who are at increasing risk for neurodegenerative and psychiatric conditions. Each participant was equipped with a smartwatch and a bespoke smartphone application designed to harvest “passive” data streams without altering their daily routines. These passive signals encompassed physiological metrics such as heart rate, physical activity patterns, sleep behavior, and external environmental factors including weather conditions and air pollution levels — resulting in 21 diverse indicators being collected continuously across ten months.

Complementing these passive measurements, participants provided “active” data every three months through self-administered questionnaires targeting emotional well-being and neurocognitive tests assessing various aspects of cognition. This dual-modal approach created a rich dataset capturing both objective biological-environmental variables and subjective psychological-cognitive states. The core innovation lay in employing advanced AI to analyze this multifaceted data, aiming to correlate subtle patterns in the passive signals with the more explicit mental health and cognitive state assessments.

Igor Matias, a doctoral assistant at UNIGE’s Research Institute for Statistics and Information Science and the study’s lead author, explained the central hypothesis: Could artificial intelligence discern meaningful predictors of brain health by mining continuous data from wearable devices? The results surpassed expectations. AI models achieved an average prediction error rate of just 12.5% when forecasting fluctuations in participants’ cognitive and emotional states, marking a significant leap toward reliable early detection of brain health deviations without intrusive clinical procedures.

Delving deeper, the study revealed that AI predicted emotional states with the highest precision, registering error rates generally between 5% and 10%. This suggests that passive physiological and environmental markers resonate strongly with transient emotional conditions and affective states. Cognitive states, inherently more complex and multifactorial, were predicted with slightly less accuracy, yielding error rates from 10% to 20%. These findings underscore the relative ease with which AI can decode emotional health signals, perhaps due to more direct links between autonomic physiological responses and emotional stimuli compared to the more nuanced and composite nature of cognitive processes.

Crucially, the researchers identified key passive indicators that were most informative in driving the AI predictions. For cognition, environmental air pollution levels, weather conditions, daily heart rate variability, and sleep quality metrics stood out as influential. In contrast, emotional state predictions heavily relied upon weather parameters, sleep variability indices, and heart rate measurements during sleep cycles. These insights not only validate previous research highlighting the profound impacts of external environment and lifestyle on brain function but also provide tangible biomarkers for continuous monitoring.

The study’s integration of environmental data alongside physiological parameters represents a pioneering holistic approach, recognizing that brain health is dynamically influenced by an interplay of intrinsic biological factors and extrinsic environmental exposures. This multidimensional perspective enhances predictive fidelity and paves the way for contextualized, personalized brain health management in everyday life. Wearable sensors thus transcend mere convenience gadgets, evolving into vital digital biomarkers capable of mapping neurological and psychological health trajectories at unprecedented temporal resolutions.

Supervised by Professors Katarzyna Wac and Matthias Kliegel, experts in digital health and cognitive aging respectively, this study forms part of the wider Providemus alz project, which aims to harness mobile technology for neurodegenerative disease monitoring and management. Encouraged by the promising results, the team is now embarking on an extended 24-month data collection phase. This next stage will delve into individual variability linked to AI model performance, exploring why certain participants’ data yield stronger predictive insights than others. Through this, the research objectives extend toward refining AI algorithms to accommodate personal traits and lifestyle nuances, ultimately enabling tailored preventative strategies and interventions.

The implications of this research are profound and manifold. By deploying AI-driven continuous brain health monitoring through everyday wearable devices, the boundaries between clinic and daily life begin to blur. Early detection of subtle cognitive decline or emotional dysregulation becomes feasible without the need for specialized infrastructure or frequent clinical visits. This democratization of brain health surveillance promises enhanced patient empowerment, more timely therapeutic responses, and potentially reduced burdens on healthcare systems increasingly strained by neuropsychiatric disorders.

At a technical level, the study highlights how machine learning models can effectively synthesize heterogeneous streams of time-series data — physiological, environmental, behavioral — spanning multiple temporal scales. Key challenges addressed include noise reduction, missing data imputation, temporally aligned feature extraction, and algorithmic interpretability. The successful integration of these complex data modalities into actionable predictions marks a significant methodological achievement, setting a benchmark for future digital biomarker research.

Moreover, this work underscores the importance of passive data collection paradigms that do not impose behavioral changes or active compliance burdens on users. By unobtrusively capturing continuous signals, the approach maximizes ecological validity and participant adherence, critical factors for long-term monitoring endeavors that seek real-world applicability beyond controlled experimental settings.

In conclusion, the University of Geneva’s study heralds a new frontier in brain health assessment, showcasing how everyday smart devices coupled with AI can detect early signs of neurological and mental illnesses with remarkable precision. As the global burden of brain disorders surges, such innovations offer hope for scalable, proactive, and personalized mental healthcare solutions. The scientific community and technology developers alike will watch keenly as this promising approach advances toward broader clinical validation and eventual integration into routine health monitoring protocols.

Subject of Research: People
Article Title: Digital biomarkers for brain health: passive and continuous assessment from wearable sensors
News Publication Date: 3-Mar-2026
Web References: http://dx.doi.org/10.1038/s41746-026-02340-y
Keywords: Digital biomarkers, brain health, artificial intelligence, wearable sensors, smartphones, smartwatches, cognitive health, emotional health, passive data collection, machine learning, neurodegenerative diseases, mental illness detection

The retina, often referred to as the “window to the brain,” contains a plethora of blood vessels and neural tissue that can provide critical insight into neurological health. Traditional diagnostic methods for evaluating brain health typically involve imaging techniques such as MRI or CT scans, which can be expensive, time-consuming, and sometimes invasive. In contrast, retinal fundus imaging offers a cost-effective and efficient alternative, allowing for quick assessments without the need for special patient preparation.

Recent advancements in imaging technology have enhanced the clarity and resolution of retinal scans, enabling the detection of pathological changes that correlate with brain conditions. Combining sophisticated imaging techniques with artificial intelligence (AI) algorithms allows for more accurate interpretations of retinal images and their implications for brain health. This study underscores the importance of integrating technology into medical practice, paving the way for more robust diagnostic tools that can improve patient outcomes.

Additionally, the use of clinical information prompts is a key development in this research. By leveraging data such as patient history, symptoms, and risk factors, healthcare professionals can better analyze the retinal images in context. This methodology not only aids in diagnosing existing conditions but also facilitates the identification of at-risk individuals who may benefit from early intervention. The integration of clinical prompts streamlines the diagnostic process, making it more personalized and effective.

The implications of these findings are profound, especially in the context of aging populations faced with growing incidences of neurodegenerative diseases such as Alzheimer’s and Parkinson’s. As the global demographic shifts towards an older population, the demand for innovative, non-invasive diagnostic tools capable of early detection is more urgent than ever. The approach detailed by Tong and colleagues could serve as a vital resource for geriatric healthcare providers, enabling prompt identification of cognitive decline at stages when interventions can be most effective.

Furthermore, the research highlights the significance of interdisciplinary collaboration in advancing medical science. The collaboration between ophthalmologists, neurologists, and data scientists exemplifies how combining diverse expertise can lead to significant breakthroughs. This synergistic approach fosters an environment of innovation, which is crucial in developing cutting-edge solutions that address complex health challenges.

The researchers conducted an extensive analysis involving a diverse cohort of participants to validate their findings. With a robust dataset, they were able to establish strong correlations between retinal alterations and various neurological markers. This empirical evidence solidifies the argument for adopting retinal imaging as a standard part of cognitive assessments, particularly in populations predisposed to brain health issues.

In addition to clinical applications, the study opens avenues for further research into the underlying mechanisms connecting retinal health and brain function. Understanding the biological pathways involved in these correlations could yield new therapeutic targets and contribute to the development of innovative treatments for neurodegenerative disorders. Future studies could explore whether interventions aimed at improving retinal health may also enhance cognitive function, thereby creating a twofold benefit.

It’s essential to consider the ethical implications of integrating AI and machine learning into healthcare practices. While the prospect of improved diagnostic accuracy is promising, it raises questions about data privacy, algorithm transparency, and the potential for bias in machine learning models. Researchers must address these challenges to ensure equitable access and trustworthy applications of technology in medicine.

As the field of medical imaging continues to evolve, the potential for integrating retinal fundus imaging in routine neurological assessments represents a significant step forward. This paradigm shift could redefine how healthcare providers approach patient evaluations and lead to more integrated care models that prioritize comprehensive health monitoring.

Ultimately, this research lays a foundation for future advancements in both diagnostic imaging and brain health evaluation. By embracing the potential of retinal imaging, healthcare systems can enhance their capabilities to monitor and promote neurological health on a larger scale. The commitment to innovation and patient-centered care is vital as we strive to address the complex challenges posed by neurological diseases and the broader implications for public health.

In conclusion, the study conducted by Tong, Hui, and Gou heralds a new era of diagnostic possibilities in the realm of brain health evaluation. Through clinical information prompt-driven retinal fundus imaging, we stand on the cusp of revolutionizing the way we approach cognitive health assessments. By integrating technological advancements with clinical practice, we can ensure that patients receive timely and effective evaluations, ultimately leading to better health outcomes and quality of life.

Subject of Research: Retinal fundus imaging for brain health evaluation.

Article Title: Clinical information prompt-driven retinal fundus image for brain health evaluation.

Article References:

Tong, N., Hui, Y., Gou, SP. et al. Clinical information prompt-driven retinal fundus image for brain health evaluation.
Military Med Res 12, 47 (2025). https://doi.org/10.1186/s40779-025-00630-2

Image Credits: AI Generated

DOI: https://doi.org/10.1186/s40779-025-00630-2

Keywords: retinal imaging, brain health, cognitive evaluation, diagnostic tools, artificial intelligence, ophthalmology, neurology.